A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 620 participants.
Also called NCT01169090
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 620 participants
- Registry
-
NCT01169090
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01169090. Randomized; double masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2011-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- SK-0403
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Sitagliptin
- Lead sponsor
- Kowa Research Institute, Inc.
Record details
- Record id
cardio:ct-nct01169090- Content hash
49368dbb9ba6e7fb80a54d831f2f6d6e00e2e1ea88c416c7da45f79f48b28d3a